Short-term outcomes of intravitreal faricimab for treatment-naïve neovascular age-related macular de...
Short-term outcomes of intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
To investigate the efficacy and safety of loading phase treatment with 3 monthly intravitreal injections of faricimab for neovascular age-related macular degeneration (nAMD).
Methods
We retrospectively analyzed 16-week outcomes of 40 consecutive eyes of 38 patients with treatment-naïve nAMD. Three monthly injections of faricimab we...
Alternative Titles
Full title
Short-term outcomes of intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2814814272
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2814814272
Other Identifiers
ISSN
0721-832X
E-ISSN
1435-702X
DOI
10.1007/s00417-023-06116-y
